Skip to main content

Glutamine Supplementation in Multiple Trauma Patients

  • Chapter
  • First Online:
Glutamine in Clinical Nutrition

Abstract

During stress conditions such as multiple trauma and critical illness, the demand for glutamine increases and its concentration in plasma and muscle falls dramatically. Therefore, glutamine has been re-classified as an essential amino acid under such catabolic conditions. The role of glutamine supplementation in trauma patients has been extensively studies. Despite the numerous clinical trials that investigated the effect of enteral and parenteral glutamine supplementation in multiple trauma patients, the results are inconclusive. Glutamine supplementation through parenteral route has been associated with reduced infectious complications, mortality, costs and hospital length of stay. However, glutamine supplementation in multiple trauma patients receiving enteral nutrition and its best route are still controversial. Although glutamine supplementation is recommended in multiple trauma patients, large well designed multi-centre trials are required to provide a confirmed conclusion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36(6):691–709.

    Article  PubMed  Google Scholar 

  2. Acosta JA, Yang JC, Winchell RJ, Simons RK, Fortlage DA, Hollingsworth-Fridlund P, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg. 1998;186(5):528–33.

    Article  CAS  PubMed  Google Scholar 

  3. Matthes G, Seifert J, Ostermann PA, Wurfel S, Ekkernkamp A, Wich M. Early death of the severly injured patient–A retrospective analysis. Zentralbl Chir. 2001;126(12):995–9.

    Article  CAS  PubMed  Google Scholar 

  4. Demetriades D, Murray J, Charalambides K, Alo K, Velmahos G, Rhee P, et al. Trauma fatalities: time and location of hospital deaths. J Am Coll Surg. 2004;198(1):20–6.

    Article  PubMed  Google Scholar 

  5. Osborn TM, Tracy JK, Dunne JR, Pasquale M, Napolitano LM. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med. 2004;32(11):2234–40.

    PubMed  Google Scholar 

  6. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995;38(2):185–93.

    Article  CAS  PubMed  Google Scholar 

  7. Napolitano LM, Faist E, Wichmann MW, Coimbra R. Immune dysfunction in trauma. Surg Clin North Am. 1999; 79(6):1385–416.

    Article  CAS  PubMed  Google Scholar 

  8. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg. 1996;20(4):454–9.

    Article  CAS  PubMed  Google Scholar 

  9. Ditschkowski M, Kreuzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid EN, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg. 1999;229(2):246–54.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Baker CC, Oppenheimer L, Stephens B, Lewis FR, Trunkey DD. Epidemiology of trauma deaths. Am J Surg. 1980;140(1):144–50.

    Article  CAS  PubMed  Google Scholar 

  11. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 1987;27(3):262–6.

    Article  CAS  PubMed  Google Scholar 

  12. Jackson NC, Carroll PV, Russell-Jones DL, Sonksen PH, Treacher DF, Umpleby AM. The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism. Am J Physiol. 1999;276(1 Pt 1):E163–70.

    CAS  PubMed  Google Scholar 

  13. De Jonghe B, Bastuji-Garin S, Durand MC, Malissin I, Rodrigues P, Cerf C, et al. Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med. 2007;35(9):2007–15.

    Article  PubMed  Google Scholar 

  14. Liu W, Lopez JM, VanderJagt DJ, Glew RH, Fry DE, Schermer C, et al. Evaluation of aminoaciduria in severely traumatized patients. Clin Chim Acta. 2002;316(1–2):123–8.

    Article  CAS  PubMed  Google Scholar 

  15. Gore DC, Wolfe RR. Glutamine supplementation fails to affect muscle protein kinetics in critically ill patients. JPEN J Parenter Enteral Nutr. 2002;26(6):342–9. discussion 49-50.

    Article  CAS  PubMed  Google Scholar 

  16. Long CL, Borghesi L, Stahl R, Clark JA, Geiger JW, DiRienzo DB, et al. Impact of enteral feeding of a glutamine-supplemented formula on the hypoaminoacidemic response in trauma patients. J Trauma. 1996;40(1):97–102.

    Article  CAS  PubMed  Google Scholar 

  17. Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001;27(1):84–90.

    Article  CAS  PubMed  Google Scholar 

  18. Mittendorfer B, Gore DC, Herndon DN, Wolfe RR. Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration. JPEN J Parenter Enteral Nutr. 1999;23(5):243–52.

    Article  CAS  PubMed  Google Scholar 

  19. Brochner AC, Toft P. Pathophysiology of the systemic inflammatory response after major accidental trauma. Scand J Trauma Resusc Emerg Med. 2009;17(1):43.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Keel M, Ecknauer E, Stocker R, Ungethum U, Steckholzer U, Kenney J, et al. Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma. J Trauma. 1996;40(6):907–12. discussion 12-4.

    Article  CAS  PubMed  Google Scholar 

  21. Lenz A, Franklin GA, Cheadle WG. Systemic inflammation after trauma. Injury. 2007;38(12):1336–45.

    Article  PubMed  Google Scholar 

  22. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24(7):1125–8.

    Article  CAS  PubMed  Google Scholar 

  23. Napolitano LM, Ferrer T, McCarter Jr RJ, Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma. 2000;49(4):647–52. discussion 52-3.

    Article  CAS  PubMed  Google Scholar 

  24. Schroder O, Laun RA, Held B, Ekkernkamp A, Schulte KM. Association of interleukin-10 promoter polymorphism with the incidence of multiple organ dysfunction following major trauma: results of a prospective pilot study. Shock. 2004;21(4):306–10.

    Article  PubMed  Google Scholar 

  25. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma. 1996;40(4):501–10. discussion 10-2.

    Article  CAS  PubMed  Google Scholar 

  26. Vermes I, Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab. 2001;15(4):495–511.

    Article  CAS  PubMed  Google Scholar 

  27. Monk DN, Plank LD, Franch-Arcas G, Finn PJ, Streat SJ, Hill GL. Sequential changes in the metabolic response in critically injured patients during the first 25 days after blunt trauma. Ann Surg. 1996;223(4):395–405.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Uehara M, Plank LD, Hill GL. Components of energy expenditure in patients with severe sepsis and major trauma: a basis for clinical care. Crit Care Med. 1999;27(7):1295–302.

    Article  CAS  PubMed  Google Scholar 

  29. Klein S, Peters EJ, Shangraw RE, Wolfe RR. Lipolytic response to metabolic stress in critically ill patients. Crit Care Med. 1991;19(6):776–9.

    Article  CAS  PubMed  Google Scholar 

  30. Wolfe RR, Martini WZ. Changes in intermediary metabolism in severe surgical illness. World J Surg. 2000; 24(6):639–47.

    Article  CAS  PubMed  Google Scholar 

  31. Frankenfield DC, Smith JS, Cooney RN. Accelerated nitrogen loss after traumatic injury is not attenuated by achievement of energy balance. JPEN J Parenter Enteral Nutr. 1997;21(6):324–9.

    Article  CAS  PubMed  Google Scholar 

  32. Gamrin L, Andersson K, Hultman E, Nilsson E, Essen P, Wernerman J. Longitudinal changes of biochemical parameters in muscle during critical illness. Metabolism. 1997;46(7):756–62.

    Article  CAS  PubMed  Google Scholar 

  33. Biolo G, Zorat F, Antonione R, Ciocchi B. Muscle glutamine depletion in the intensive care unit. Int J Biochem Cell Biol. 2005;37(10):2169–79.

    Article  CAS  PubMed  Google Scholar 

  34. Arnold J, Campbell IT, Samuels TA, Devlin JC, Green CJ, Hipkin LJ, et al. Increased whole body protein breakdown predominates over increased whole body protein synthesis in multiple organ failure. Clin Sci. 1993;84(6): 655–61.

    CAS  PubMed  Google Scholar 

  35. Gore DC, Jahoor F. Glutamine kinetics in burn patients. Comparison with hormonally induced stress in volunteers. Arch Surg. 1994;129(12):1318–23.

    Article  CAS  PubMed  Google Scholar 

  36. Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet. 1998;352(9130): 772–6.

    Article  CAS  PubMed  Google Scholar 

  37. Weingartmann G, Oehler R, Derkits S, Oismuller C, Fugger R, Roth E. HSP70 expression in granulocytes and lymphocytes of patients with polytrauma: comparison with plasma glutamine. Clin Nutr. 1999;18(2):121–4.

    Article  CAS  PubMed  Google Scholar 

  38. Parry-Billings M, Baigrie RJ, Lamont PM, Morris PJ, Newsholme EA. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg. 1992;127(10):1237–40.

    Article  CAS  PubMed  Google Scholar 

  39. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns? Lancet. 1990;336(8714):523–5.

    Article  CAS  PubMed  Google Scholar 

  40. Askanazi J, Carpentier YA, Michelsen CB, Elwyn DH, Furst P, Kantrowitz LR, et al. Muscle and plasma amino acids following injury. Influence of intercurrent infection. Ann Surg. 1980;192(1):78–85.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Boelens PG, Houdijk AP, Fonk JC, Nijveldt RJ, Ferwerda CC, Von Blomberg-Van Der Flier BM, et al. Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr. 2002;132(9): 2580–6.

    CAS  PubMed  Google Scholar 

  42. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev. 1990;48(8):297–309.

    Article  CAS  PubMed  Google Scholar 

  43. Heyland DK, Dhaliwalm R, Day A, Drover J, Cote H, Wischmeyer P. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study. JPEN J Parenter Enteral Nutr. 2007; 31(2):109–18.

    Article  CAS  PubMed  Google Scholar 

  44. Sacks GS. The data in support of glutamine supplementation. Nutr Clin Pract. 2003;18(5):386–90.

    Article  PubMed  Google Scholar 

  45. Weingartmann G, Fridrich P, Mauritz W, Gotzinger P, Mittlbock M, Germann P, et al. Safety and efficacy of increasing dosages of glycyl-glutamine for total parenteral nutrition in polytrauma patients. Wien Klin Wochenschr. 1996; 108(21):683–8.

    CAS  PubMed  Google Scholar 

  46. Berg A, Forsberg E, Wernerman J. The local vascular tolerance to an intravenous infusion of a concentrated glutamine solution in ICU patients. Clin Nutr. 2002;21(2):135–9.

    Article  CAS  PubMed  Google Scholar 

  47. Berg A, Rooyackers O, Norberg A, Wernerman J. Elimination kinetics of L-alanyl-L-glutamine in ICU patients. Amino Acids. 2005;29(3):221–8.

    Article  CAS  PubMed  Google Scholar 

  48. Berg A, Bellander BM, Wanecek M, Gamrin L, Elving A, Rooyackers O, et al. Intravenous glutamine supplementation to head trauma patients leaves cerebral glutamate concentration unaffected. Intensive Care Med. 2006;32(11):1741–6.

    Article  CAS  PubMed  Google Scholar 

  49. Berg A, Bellander BM, Wanecek M, Norberg A, Ungerstedt U, Rooyackers O, et al. The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients. Clin Nutr. 2008;27(6):816–21.

    Article  CAS  PubMed  Google Scholar 

  50. Tjäder I, Rooyackers O, Forsberg AM, Vesali RF, Garlick PJ, Wernerman J. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med. 2004;30(2):266–75.

    Article  PubMed  Google Scholar 

  51. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30(9):2032–7.

    Article  CAS  PubMed  Google Scholar 

  52. Fuentes-Orozco C, Anaya-Prado R, Gonzalez-Ojeda A, Arenas-Marquez H, Cabrera-Pivaral C, Cervantes-Guevara G, et al. L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004;23(1):13–21.

    Article  CAS  PubMed  Google Scholar 

  53. Zhou Y-P, Jiang Z-M, Sun Y-H, He G-Z, Shu H. The effects of supplemental glutamine dipeptide on gut integrity and clinical outcome after major escharectomy in severe burns: a randomized, double-blind, controlled clinical trial. Clin Nutr Suppl. 2004;1(1):55–60.

    Article  CAS  Google Scholar 

  54. Dechelotte P, Hasselmann M, Cynober L, Allaouchiche B, Coeffier M, Hecketsweiler B, et al. L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006; 34(3):598–604.

    Article  CAS  PubMed  Google Scholar 

  55. Grau T, Bonet A, Minambres E, Pineiro L, Irles JA, Robles A, et al. The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med. 2011;39(6):1263–8.

    Article  CAS  PubMed  Google Scholar 

  56. Conejero R, Bonet A, Grau T, Esteban A, Mesejo A, Montejo JC, et al. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition. 2002;18(9):716–21.

    Article  CAS  PubMed  Google Scholar 

  57. Garrel D, Patenaude J, Nedelec B, Samson L, Dorais J, Champoux J, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit Care Med. 2003;31(10):2444–9.

    Article  CAS  PubMed  Google Scholar 

  58. Zhou YP, Jiang ZM, Sun YH, Wang XR, Ma EL, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr. 2003;27(4):241–5.

    Article  CAS  PubMed  Google Scholar 

  59. Peng X, Chen RC, Wang P, You ZY, Wang SL. Effects of enteral supplementation with glutamine on mitochondria respiratory function of intestinal epithelium in burned rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004; 16(2):93–6.

    CAS  PubMed  Google Scholar 

  60. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition. 1999;15(2):108–15.

    Article  CAS  PubMed  Google Scholar 

  61. Brantley S, Pierce J. Effects of enteral glutamine on trauma patients. Nutr Clin Pract. 2000;15:S13.

    Article  Google Scholar 

  62. Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med. 2003;29(10):1710–6.

    Article  PubMed  Google Scholar 

  63. Schulman AS, Willcutts KF, Claridge JA, Evans HL, Radigan AE, O'Donnell KB, et al. Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med. 2005;33(11):2501–6.

    Article  CAS  PubMed  Google Scholar 

  64. McQuiggan M, Kozar R, Sailors RM, Ahn C, McKinley B, Moore F. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN J Parenter Enteral Nutr. 2008;32(1):28–35.

    Article  PubMed  Google Scholar 

  65. Luo M, Bazargan N, Griffith DP, Estivariz CF, Leader LM, Easley KA, et al. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: a pilot study. Clin Nutr. 2008;27(2):297–306.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Melis GC, Boelens PG, van der Sijp JR, Popovici T, De Bandt JP, Cynober L, et al. The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients. Br J Nutr. 2005;94(1):19–26.

    Article  CAS  PubMed  Google Scholar 

  67. Haisch M, Fukagawa NK, Matthews DE. Oxidation of glutamine by the splanchnic bed in humans. Am J Physiol Endocrinol Metab. 2000;278(4):E593–602.

    CAS  PubMed  Google Scholar 

  68. Ligthart-Melis GC, van de Poll MC, Dejong CH, Boelens PG, Deutz NE, van Leeuwen PA. The route of administration (enteral or parenteral) affects the conversion of isotopically labeled L-[2-15 N]glutamine into citrulline and arginine in humans. JPEN J Parenter Enteral Nutr. 2007;31(5):343–8. discussion 49-50.

    Article  CAS  PubMed  Google Scholar 

  69. Wischmeyer PE, Lynch J, Liedel J, Wolfson R, Riehm J, Gottlieb L, et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001;29(11):2075–80.

    Article  CAS  PubMed  Google Scholar 

  70. Bakalar B, Duska F, Pachl J, Fric M, Otahal M, Pazout J, et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med. 2006;34(2):381–6.

    Article  CAS  PubMed  Google Scholar 

  71. Eroglu A. The effect of intravenous alanyl-glutamine supplementation on plasma glutathione levels in intensive care unit trauma patients receiving enteral nutrition: the results of a randomized controlled trial. Anesth Analg. 2009;109(2):502–5.

    Article  CAS  PubMed  Google Scholar 

  72. Schulman AS, Willcutts KF, Claridge JA, O'Donnell KB, Radigan AE, Evans HL, et al. Does enteral glutamine supplementation decrease infectious morbidity? Surg Infect (Larchmt). 2006;7(1):29–35.

    Article  Google Scholar 

  73. Yang DL, Xu JF. Effect of dipeptide of glutamine and alanine on severe traumatic brain injury. Chin J Traumatol. 2007;10(3):145–9.

    CAS  PubMed  Google Scholar 

  74. Schirmer CM, Kornbluth J, Heilman CB, Bhardwaj A. Gastrointestinal prophylaxis in neurocritical care. Neurocrit Care. 2012;16(1):184–93.

    Article  PubMed  Google Scholar 

  75. Beale RJ, Sherry T, Lei K, Campbell-Stephen L, McCook J, Smith J, et al. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial. Crit Care Med. 2008;36(1):131–44.

    Article  CAS  PubMed  Google Scholar 

  76. Macfie J. European round table: the use of immunonutrients in the critically ill. Clin Nutr. 2004;23(6):1426–9.

    Article  CAS  PubMed  Google Scholar 

  77. Wernerman J. Glutamine and acute illness. Curr Opin Crit Care. 2003;9(4):279–85.

    Article  PubMed  Google Scholar 

  78. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23(10):1638–52.

    Article  CAS  PubMed  Google Scholar 

  79. Long CL, Nelson KM, DiRienzo DB, Weis JK, Stahl RD, Broussard TD, et al. Glutamine supplementation of enteral nutrition: impact on whole body protein kinetics and glucose metabolism in critically ill patients. JPEN J Parenter Enteral Nutr. 1995;19(6):470–6.

    Article  CAS  PubMed  Google Scholar 

  80. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk Jr HC. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg. 1990;77(2):204–7.

    Article  CAS  PubMed  Google Scholar 

  81. Pérez-Bárcena J, Crespí C, Regueiro V, Marsé P, Raurich JM, Ibáñez J, et al. Lack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unit. Crit Care. 2010; 14(6):R233.

    Article  PubMed Central  PubMed  Google Scholar 

  82. Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489–97.

    Article  CAS  PubMed  Google Scholar 

  83. Houdijk AP, Nijveldt RJ, van Leeuwen PA. Glutamine-enriched enteral feeding in trauma patients: reduced infectious morbidity is not related to changes in endocrine and metabolic responses. JPEN J Parenter Enteral Nutr. 1999;23(5 Suppl):S52–8.

    Article  CAS  PubMed  Google Scholar 

  84. Wischmeyer PE. Clinical applications of L-glutamine: past, present, and future. Nutr Clin Pract. 2003;18(5): 377–85.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ruqaiya M. Al Balushi B.Sc., M.Sc., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Al Balushi, R.M., Paratz, J.D., Cohen, J., Banks, M. (2015). Glutamine Supplementation in Multiple Trauma Patients. In: Rajendram, R., Preedy, V., Patel, V. (eds) Glutamine in Clinical Nutrition. Nutrition and Health. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1932-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1932-1_14

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1931-4

  • Online ISBN: 978-1-4939-1932-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics